New drug combo shows promise in wiping out breast cancer before surgery
Disease control
Ongoing
This study tests whether adding the drug pyrotinib to standard chemotherapy before surgery can completely eliminate HER2-positive early breast cancer in 113 women. Participants receive a combination of drugs, then surgery, and are followed for cancer recurrence. The goal is to se…
Phase: PHASE2, PHASE3 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated May 11, 2026 20:46 UTC